Sign in

CIK 0001023024 · Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
582301143
Phone
6097591810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
  1. 4 Open-market sale SVP, HEAD - ESTABLISHED BRANDS sold 4,772 shares at $74.91 ($357,471)
  2. 4 Planned sale HEAD OF RARE DISEASE sold 3,162 shares at $71.64 ($226,526)
  3. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $72.62 ($36,310)
  4. 4 Planned sale HEAD OF RARE DISEASE sold 5,723 shares at an average $74.19 ($424,617)
  5. 4 Shares withheld for taxes PRESIDENT & CEO gave up 17,060 shares (to pay taxes)
  6. 4 Shares withheld for taxes SVP, GENERICS gave up 3,314 shares (to pay taxes)
  7. 4 Planned sale SVP, CHIEF HR OFFICER sold 6,572 shares at an average $74.33 ($488,474)
  8. 4 Shares withheld for taxes SVP & CFO gave up 5,150 shares (to pay taxes)
  9. 4 Open-market sale SVP & CFO sold 7,312 shares at an average $75.50 ($552,031)
  10. 144 Insider Sale of Securities
  11. 4 Planned sale HEAD OF RARE DISEASE sold 417 shares at $74.00 ($30,858)
  12. 4 Open-market sale SVP, GENERICS sold 2,060 shares at $76.50 ($157,590)
  13. 4 Open-market sale Director sold 6,000 shares at $74.23 ($445,380)
  14. 144 Insider Sale of Securities
  15. 8-K Event Regulation FD disclosure
  16. 4 Grant or award HEAD OF R&D, COO-NOVITIUM OPS acquired 11,116 shares (grant or award)
  17. 4 Grant or award SVP, HEAD - ESTABLISHED BRANDS acquired 6,021 shares (grant or award)
  18. 4 Grant or award HEAD OF RARE DISEASE acquired 21,306 shares (grant or award)
  19. 4 Grant or award PRESIDENT & CEO acquired 75,592 shares (grant or award)
  20. 4 Grant or award SVP, GENERICS acquired 12,969 shares (grant or award)

Page 4 of 90 · 1,784 filings